Hypophosphatasia: Clinical Trials

4 trials for Hypophosphatasia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 active not recruiting, 1 completed. 4 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 34Active not recruiting 3, Completed 1
Phase 21Completed 1

Follow Hypophosphatasia: new trials by email Literature Review of Hypophosphatasia trials Research Report on Hypophosphatasia

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase 3 Study of ALXN1850 in Treatment-Naïve Pediatric Participants With HPP
ALXN1850, Placebo - Hypophosphatasia
Phase 3Active not recruitingAlexion Pharmaceuticals, Inc.302024-05-142026-05-28
Phase 3 Study of ALXN1850 in Pediatric Participants With HPP Previously Treated With Asfotase Alfa
ALXN1850, asfotase alfa - Hypophosphatasia
Phase 3Active not recruitingAlexion Pharmaceuticals, Inc.432024-04-022026-05-05
Phase 3 Study of ALXN1850 Versus Placebo in Adolescent and Adult Participants With HPP Who Have Not Previously Been Treated With Asfotase Alfa
ALXN1850, Placebo - Hypophosphatasia
Phase 3Active not recruitingAlexion Pharmaceuticals, Inc.1242024-01-032026-06-22
Open-Label Study of Asfotase Alfa in Infants and Children ≤ 5 Years of Age With Hypophosphatasia (HPP)
asfotase alfa - Hypophosphatasia
Phase 2 / Phase 3CompletedAlexion Pharmaceuticals, Inc.692010-07-012019-03-13

Narrower conditions

Bone Diseases (1)  ·  Osteomalacia (1)  ·  Rickets (1)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (4)  ·  Genetic Diseases, Inborn (4)  ·  Metabolic Diseases (4)  ·  Metabolism, Inborn Errors (4)  ·  Metal Metabolism, Inborn Errors (4)  ·  Nutritional and Metabolic Diseases (4)  ·  Avitaminosis (1)  ·  Bone Diseases, Metabolic (1)  ·  Calcium Metabolism Disorders (1)  ·  Deficiency Diseases (1)  ·  Malnutrition (1)  ·  Musculoskeletal Diseases (1)  ·  Nutrition Disorders (1)  ·  Vitamin D Deficiency (1)

Interventions

asfotase alfa (2)

Sponsors

Alexion Pharmaceuticals, Inc. (4)

Countries

Australia (4)  ·  Canada (4)  ·  Turkey (Türkiye) (4)  ·  United Kingdom (4)  ·  United States (4)  ·  Japan (3)  ·  Spain (3)  ·  Argentina (2)  ·  Brazil (2)  ·  China (2)  ·  France (2)  ·  Germany (2)  ·  Israel (2)  ·  Italy (2)  ·  Poland (2)

Results publications

PMID 26529632, PMID 30811537, PMID 32762706